Results 101 to 110 of about 46,339 (291)

Survival differences according to baseline characteristics of patient with advanced heart failure treated with levosimendan

SAGE Open Medicine
Aims: To assess whether baseline characteristics (age, New York Heart Association functional class, left ventricular ejection fraction, glomerular filtration rate, systolic blood pressure, and N-terminal pro-brain natriuretic peptide) predicted different
Angel-Alberto Garcia-Peña, Alejandro Mariño, Oscar-Mauricio Muñoz-Velandia, Daniela Saa-González   +3 more
doaj   +1 more source

Changes in the Levels of Modern Biomarkers in Patients with Decompensated Heart Failure After Myocardial Infarction Under the Influence of Treatment with Succinic Acid and Arginine Preparations

Galician Medical Journal, 2019
The prevalence of heart failure in Europe and worldwide is high. This syndrome is a common cause of hospitalization and has a significant impact on morbidity, mortality and healthcare costs in highly developed countries.
Khrystyna Levandovska
doaj   +1 more source

Plasma Cardiac Troponin I Concentration and Cardiac Death in Cats with Hypertrophic Cardiomyopathy [PDF]

, 2014
BACKGROUND: The use of cardiac biomarkers to assist in the diagnosis of occult and symptomatic hypertrophic cardiomyopathy (HCM) in cats has been established. There is limited data describing their prognostic utility in cats with HCM.
Abbott, Atkins, Bang, Blume, Chan, Christiaans, Coats, Connolly, Connolly, Connolly, Fernandes, Fox, Fox, Fox, Gersh, Geske, Herndon, Humm, Kittleson, Kubo, Kubo, Langhorn, Lefbom, Lyons, Maron, Maron, Maron, Moreno, Ohno-Machado, Oyama, Paige, Payne, Payne, Peacock, Perna, Perna, Rush, Schober, Schober, Schober, Singletary, Trehiou-Sechi, Wagner, Wess   +43 more
core   +2 more sources

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects

Российский кардиологический журнал, 2006
The authors studied N-terminal pro-brain natriuretic peptide (N-proBNP) role in 43 essential arterial hypertension (EAH) patients, as well as antihypertensive therapy effects on N-proBNP. N-proBNP levels were independent of gender or age.
A. S. Galyavich, E. R. Valiullina
doaj  

B‐cell maturation antigen chimeric antigen receptor‐T therapy alleviated heart failure in patients with multiple myeloma

ESC Heart Failure
Patients with multiple myeloma (MM) are likely to achieve poor therapeutic response when organs are involved. We produced anti‐B‐cell maturation antigen (BCMA) chimeric antigen receptor (CAR)‐T cells, which are in a trial for patients with relapsed ...
Yunhong Wang, Ke Zhang, Xiaohui Suo, Ning Meng, Yuanrui Gu, Yilang Qin, Yanxia Tu, Xiaohui Zhang, Guofeng Sun, Jiaojiao Ji, Weichun Wu, Yuqi Cai, Kai Yang, Chenxi Ouyang, Junyuan Qi   +14 more
doaj   +1 more source

Prevalence of subclinical myocardial involvement among acute rheumatic fever patients without overt clinical carditis in Northern India: An evidence from plasma N-terminal pro-brain natriuretic peptide assessment

Heart India, 2017
Objectives: It is important to diagnose subclinical carditis in acute rheumatic fever (ARF) since it has a bearing on prognosis and duration of prophylaxis. Plasma N-terminal pro-brain natriuretic peptide (NT pro-BNP) has been used as both diagnostic and
Anupam Mehrotra, Varun Shankar Narain, Rishi Sethi, Sudhanshu kumar Dwivedi, Sharad Chandra, Gaurav kumar Chaudhary   +5 more
doaj   +1 more source

N-terminal pro-brain natriuretic peptide current trends in diagnostics

IP Indian Journal of Immunology and Respiratory Medicine
N-terminal pro-brain natriuretic peptide is the prime standard biomarker used for heart diagnosis and prognosis. Owing to the acute response and considerable half-life, the N-terminal pro-brain natriuretic peptide is the most reliable biomarker to identify a cardiac injury.
Ajaikumar Sukumaran, Haritha P Raveendran, Arun R Krishnan, Jofy K Paul, D M Vasudevan   +4 more
openaire   +1 more source

A biomarker guided approach in heart failure [PDF]

, 2014
Heart failure is one of the commonest diagnoses presenting to physicians in the community or hospital care. Symptoms are often subjective, with clinicians having to rely on clinical assessment and radiological imaging to manage these patients.
Abela, Mark
core  

B-type natriuretic peptide-guided treatment for heart failure [PDF]

, 2016
Background Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. Symptoms of heart failure include breathlessness, fatigue and fluid retention.
Bankhead, Clare, Clements, Alison M, Glasziou, Paul P, Heneghan, Carl J., Kearley, Karen E, McLellan, Julie, Perera, Rafael, Pidduck, Nicola, Roberts, Nia W, Tyndel, Sally, Wright, F Lucy   +10 more
core   +1 more source